Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ocugen stock gains after fda nod to initiate phase 3

OCGN - Ocugen stock gains after FDA nod to initiate Phase 3 trial of gene therapy candidate

Ocugen, Inc.

2024-04-08 07:10:32 ET

Ocugen ( NASDAQ: OCGN ) shares gained 7% premarket on Monday after the U.S. Food and Drug Administration (FDA) cleared the firm’s investigational new drug amendment to initiate a late-stage clinical trial of its gene therapy product candidate....

For further details see:

Ocugen stock gains after FDA nod to initiate Phase 3 trial of gene therapy candidate
Stock Information
Company Name: Ocugen, Inc.
Stock Symbol: OCGN
Market: NYSE
Menu
OCGN OCGN Quote OCGN Short OCGN News OCGN Articles OCGN Message Board
Get OCGN Alerts

News, Short Squeeze, Breakout and More Instantly...